文献速递气道管理术前评估与围术期医学

COVID-19机械通气患者插管前使用高流量鼻导管氧疗与院内死亡风险增加相关

Mechanically Ventilated Patients With Coronavirus Disease 2019 Had a Higher Chance of In-Hospital Death If Treated With High-Flow Nasal Cannula Oxygen Before Intubation.
PubMed 文献 · Anesth Analg · 2022-11-04

这项单中心回顾性研究纳入2020年3月至2021年3月因COVID-19相关呼吸衰竭需要HFNC、插管或两者的440例患者,其中311例(70.7%)在插管前接受HFNC,129例(29.3%)直接插管。校正多种混杂因素后,插管前使用HFNC与院内死亡风险升高相关(HR 2.08;95%CI 1.06-4.05),成功拔管几率无差异(0.70;95%CI 0.41-1.20)。

要点

  • COVID-19呼吸衰竭机械通气患者插管前使用HFNC与院内死亡风险升高相关。
  • 插管前HFNC组与直接插管组成功拔管几率无显著差异。
  • 初始呼吸支持方式选择需权衡插管风险与HFNC可能相关的死亡风险。

核心结论

  • 在因COVID-19呼吸衰竭需要机械通气的患者中,插管前接受HFNC者院内死亡风险更高。

研究设计与样本

  • 单中心回顾性研究,纳入2020年3月至2021年3月因COVID-19相关呼吸衰竭需要HFNC、插管或两者的患者共440例。
  • 311例(70.7%)插管前接受HFNC,129例(29.3%)未使用HFNC直接插管。
  • 使用Cox比例风险模型校正年龄、性别、种族/族裔、肥胖、高血压、糖尿病、既往COPD或哮喘、HCO3、CO2、S:F比值、脉搏、呼吸频率、体温及干预前住院时间。

主要发现

  • 插管前使用HFNC组院内死亡风险高于直接插管组(HR 2.08;95%CI 1.06-4.05)。
  • 两组成功拔管几率无差异(0.70;95%CI 0.41-1.20)。

临床怎么用

  • 对COVID-19呼吸衰竭患者选择初始呼吸支持方式时,应权衡插管风险与HFNC可能相关的院内死亡风险增加。

局限性

  • 单中心回顾性研究设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of high-flow nasal cannula (HFNC) on outcomes of patients with respiratory failure from coronavirus disease 2019 (COVID-19) is unknown. We sought to assess whether exposure to HFNC before intubation was associated with successful extubation and in-hospital mortality compared to patients receiving intubation only. METHODS: This single-center retrospective study examined patients with COVID-19-related respiratory failure from March 2020 to March 2021 who required HFNC, intubation, or both. Data were abstracted from the electronic health record. Use and duration of HFNC and intubation were examined' as well as demographics and clinical characteristics. We assessed the association between HFNC before intubation (versus without) and chance of successful extubation and in-hospital death using Cox proportional hazards models adjusting for age, sex, race/ethnicity, obesity, hypertension, diabetes, prior chronic obstructive pulmonary disease or asthma, HCO 3 , CO 2 , oxygen-saturation-to-inspired-oxygen (S:F) ratio, pulse, respiratory rate, temperature, and length of stay before intervention. RESULTS: A total of n = 440 patients were identified, of whom 311 (70.7%) received HFNC before intubation, and 129 (29.3%) were intubated without prior use of HFNC. Patients who received HFNC before intubation had a higher chance of in-hospital death (hazard ratio [HR], 2.08; 95% confidence interval [CI], 1.06-4.05). No difference was found in the chance of successful extubation between the 2 groups (0.70, 0.41-1.20). CONCLUSIONS: Among patients with respiratory failure from COVID-19 requiring mechanical ventilation, patients receiving HFNC before intubation had a higher chance of in-hospital death. Decisions on initial respiratory support modality should weigh the risks of intubation with potential increased mortality associated with HFNC.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Nurok M, Friedman O, Driver M, et al. Mechanically Ventilated Patients With Coronavirus Disease 2019 Had a Higher Chance of In-Hospital Death If Treated With High-Flow Nasal Cannula Oxygen Before Intubation. Anesth Analg. 2022. PMID: 36730796. doi:10.1213/ANE.0000000000006211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。